Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas
NCT ID: NCT07157059
Last Updated: 2025-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-05-12
2024-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Racial Disparities in Severe Maternal Morbidity
NCT04879797
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
NCT05678699
Holistic Care Partner Program Feasibility and Acceptability
NCT06520566
Cultural Competency, Risk Management, and Patient Safety Internet-Based Curriculum for OB/GYN Resident Physicians
NCT02355847
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
NCT05987059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Doula-Enhanced Care Group
This group received doula-enhanced care along with routine pregnancy care.
Doula Care
Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.
Routine Pregnancy Care Group
This group received routine pregnancy care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doula Care
Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received care and plan to delivery at the University of Kansas Medical Center
* Scored positive to social determinants of health screener
* Gestational age between 14-27.6 weeks at enrollment
Exclusion Criteria
* Patients who are not willing to be randomized into not receiving doula enhanced
* Patients who do not plan to delivery at the University of Kansas Health System
* Non-Black birthing people.
* Planned cesarean section
* Patients with a known major fetal anomaly
* Non-English speaking
16 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioNexus KC
UNKNOWN
Blue KC (Blue Cross Blue Shield)
UNKNOWN
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angela Martin, MD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FP00000002
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB STUDY00149318
Identifier Type: OTHER
Identifier Source: secondary_id
STUDY00161314
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.